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Copyright © 2009 JCBN Summary Pathogenic bacterial components play critical roles in initiation of gastrointestinal
inflammation via activation of intracellular signaling pathways which induce proinflammatory
cytokines such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β. Lansoprazole
(LANSO), a proton pump inhibitor, has been widely used for the treatment of peptic ulcers
and reflux esophagitis due to its potent acid-suppressive effect. It has also been reported to
have anti-inflammatory effects. In this study we investigated the effects of LANSO on the
production of TNF-α and IL-1β induced by lipopolysaccharide (LPS) and Helicobacter pylori
water-soluble extract (HpWE) in the human monocytic cell line (THP-1). LANSO (100 μM)
significantly reduced mRNA expression and production of TNF-α and IL-1β by THP-1 cells
stimulated by LPS and HpWE. LANSO inhibited phosphorylation and degradation of inhibitory
factor  κB-α (IκB-α) and phosphorylation of extracellular signal-regulated kinase (ERK)
induced by LPS and HpWE in THP-1 cells. These findings suggest that LANSO exerts anti-
inflammatory effects by suppressing induction of TNF-α and IL-1β via inhibition of nuclear
factor (NF)-κB and ERK activation.
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Introduction
Pathogenic bacteria play crucial roles in the pathophysio-
logy of gastrointestinal inflammation. For instance, Helico-
bacter pylori ( H. pylori) infection is strongly associated
with chronic active gastritis [1–3]. Enterobacteria contribute
to the pathogenesis of inflammatory bowel diseases [4].
Moreover, recent studies suggest that the presence of entero-
bacteria is essential for the development of nonsteroidal
anti-inflammatory drugs (NSAIDs)-induced small intestinal
injury [5–7].
In the process of gastrointestinal inflammation triggered
by bacteria, binding of bacterial components to receptors on
the surface of effector cells including monocytes/macro-
phages is a critical initial step [8]. Proinflammatory
responses initiated by bacteria are elicited by the interaction
of bacterial components with Toll-like receptors (TLRs)
expressed on monocytes/macrophages [9]. For example,
lipopolysaccharide (LPS), derived from outer membrane ofLansoprazole Inhibits TNF-α and IL-1β Production
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Gram-negative bacteria, binds to TLR4, and signaling by it
leads to activation of nuclear factor (NF)-κB and mitogen-
activated protein kinase (MAPK) signaling pathways, which
subsequently induce a variety of genes involved in inflam-
matory responses such as tumor necrosis factor (TNF)-α and
interleukin(IL)-1β. It also appears that H. pylori stimulates
TLR, although the subtype responsible for this remains
controversial [10,  11]. These intracellular signaling path-
ways from receptors to the nucleus could be a therapeutic
target for prevention and regulation of deleterious inflam-
matory responses which may lead to progression of disease
or impairment of gastrointestinal physiological function.
Lansoprazole (LANSO), a proton pump inhibitor, has
been widely used for the treatment of peptic ulcers and
reflux esophagitis due to its potent acid-suppressive effects
mediated via inhibition of p-type H+ K+-adenosine triphos-
phatase. LANSO has also been reported to have anti-
inflammatory effects [12–22]. However, the precise mecha-
nism of its anti-inflammatory effects remains unclear.
In this study, we investigated the effects of LANSO on
LPS- or H. pylori-induced production of TNF-α and IL-1β
by the human monocytic cell line THP-1 and attempted to




LPS (Escherichia coli O55:B5), pyrrolidinedithio-
carbamate (PDTC), an inhibitor of NF-κB activation, and
PD98059, a MAPK/extracellular signal-regulated kinase
(ERK) kinase (MEK) inhibitor, were purchased from Sigma
(St. Louis, MO). Antibody to inhibitory factor κB-α (IκB-α)
and phosphorylated IκB-α was purchased from Cell
Signaling Technology (Danvers, MA), and antibody for
ERK2 and phosphorylated ERK2 was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). LANSO was a gift
from Takeda Pharmaceuticals (Osaka, Japan).
Preparation of H. pylori water-soluble extract (HpWE)
H. pylori (ATCC 43505 strain, cag A+ and vac A+) was
grown to a concentration of 2.0 × 108 colony-forming units
(CFUs)/ml in Brucella broth (BBL, Cockeysville, MD)
containing 10% sterile heat-inactivated horse serum. The
flasks were incubated at 37°C for 24 h under micro-
aerophilic conditions with agitation on a rotary shaker at
160 rpm. After centrifugation of H. pylori-containing broth
culture at 8300 rpm for 20 min at 4°C, supernatant was
discarded and cold PBS was added to the tube. After
washing the bacterial pellet with gentle inversion, the
bacterial suspension was centrifuged at 8300 rpm for 10 min
at 4°C. This washing procedure was repeated three times,
and finally the cell suspension was sonicated for 30 s. The
suspension was then centrifuged at 14000 rpm for 30 min at
4°C. The supernatant was then passed through a 0.22 μm
filter unit (Nihon Millipore KK, Tokyo, Japan). This
procedure removes much of the high-molecular-weight
complex material, which mainly consists of membrane
vesicles and intact flagella. Filtered supernatant was stored
at −80°C until experimentation.
Cell culture
THP-1 was purchased from American Type Culture
Collection (Manassas, VA). Cells were routinely maintained
in RPMI 1640 medium supplemented with 10% fetal bovine
serum. LPS (10 ng/mL) or HpWE (5 μg/ml) was added and
incubated for up to 3 h with or without preincubation with
LANSO (100 μM) dissolved in dimethyl sulfoxide (DMSO)
for 3 h. In another series of experiments, cells were
pretreated with 100 μM of PDTC or 10 μM or PD98059
for 30 min and LPS or HpWE was added and incubated
for 3 h.
Enzyme-linked Immunosorbent Assay (ELISA)
Cell culture supernatant was collected and production of
TNF-α and IL-1β was determined using a commercial
ELISA kit (R&D Systems, Minneapolis, MN) according to
the manufacturer’s instructions.
Determination of expression of mRNA for TNF-α and IL-1β
by real-time quantitative RT-PCR
Total RNA was isolated using an ISOGEN kit (Nippon
Gene, Tokyo, Japan) according to the manufacturer’s
protocol. PCR primers and TaqMan probes for TNF-α and
IL-1β were designed using Primer Express, a software
program (PE Applied Biosystems, Foster City, CA).
TaqMan probes were labeled with a reporter fluorescent dye
(6-carboxyfluorescein) at the 5’ end and a fluorescent dye
quencher (6-carboxytetramethylrhodamine) at the 3’ end.
For TNF-α, the sense primer was 5-TCATGCACCACCAT-
CAAGGA-3, the antisense primer was 5-GAGGCAACCT-
GACCACTCTCC-3, and the TaqMan probe was 5-
AATGGGCTTTCCGAATTCACTGGAGC-3. For IL-1β, the
sense primer was 5-ACAGGCTCCGAGATGAACAAC-3,
the antisense primer was 5-CCATTGAGGTGGAGA-
GCTTTC-3, and the TaqMan probe was 5-AAAAAGC-
CTCGTGCTGTCGGACCCATAT-3. Real-time quantitative
RT-PCR analyses were performed using an ABI PRISM
7700 Sequence Detection System instrument and software
(PE Applied Biosystems). The reaction mixture was
prepared according to the manufacturer’s protocol using
the Platinum qRT-PCR ThermoScript One-Step System
(Invitrogen, Carlsbad, CA). Thermal cycling conditions
comprised 50°C for 30 min and 95°C for 5 min, followed
by 45 cycles of amplification at 95°C for 15 s and 60°C
for 1 min. Total RNA was subjected to real-time quantitativeT. Tanigawa et al.
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RT-PCR for measurement of target genes and GAPDH as an
internal standard using TaqMan GAPDH control reagents
(PE Applied Biosystems). Expression of mRNA for TNF-α
and IL-1β was standardized to GAPDH mRNA and mRNA
levels were expressed as ratios to the mean value for vehicle
(DMSO)-treated control cells.
Western blot analysis
Cells were homogenized and lysed on ice in a buffer
containing 0.5% NP-40, 40 mM Tris HCl (pH 8.0), 120 mM
NaCl and a protease inhibitor cocktail (Complete Mini,
Pierce, Rockford, IL). Protein in the lysate was measured
with a modified bicinchoninic acid method (Pierce,
Rockford, IL). Proteins were denatured with SDS sample
buffer, subjected to SDS-polyacrylamide gel electro-
phoresis, and transferred to a PVDF membrane. Membranes
were blocked in TBS buffer containing 5% skim milk and
were then incubated overnight with antibodies to IκB-α,
phosphorylated IκB-α, phosphorylated ERK, or ERK2.
The bound antigen-antibody complexes were detected with
anti-rabbit or mouse IgG-HRP, using enhanced chemilumi-
nescence in accordance with the manufacturer’s instructions
(Amersham, Arlington Heights, IL).
Statistical Analysis
Values are the mean ± SD. One-way analysis of variance
was used to test for significance of differences among treat-
ment group means, and results were examined by Fisher’s
protected least-significant-difference test. Differences with
p values less than 0.05 were considered significant.
Results
LANSO inhibits LPS-induced TNF-α and IL-1β gene expres-
sion and protein production
Although unstimulated THP-1 cells constitutively express
mRNA for TNF-α and IL-1β, production of TNF-α and
IL-1β protein was not detected in culture supernatant in
which THP-1 cells were grown for 6 h by ELISA because of
the sensitivity of the experimental system used in the present
study. LPS increased expression of mRNA for TNF-α
by 176-fold after one-hr and by 185-fold after two-hr
incubation with LPS. Similar to TNF-α, LPS induced
expression of mRNA for IL-1β by 319-fold after one-hr and
802-fold after two-hr incubation with LPS. LPS induced
protein production of TNF-α and IL-1β after 3 h of incuba-
tion with LPS. Pretreatment with 100 μM of LANSO for 3 h
decreased LPS-induced expression of mRNA for TNF-α by
57% and protein production of TNF-α protein by 51%. LPS
also inhibited expression of mRNA for IL-1β by 62% and
protein production of IL-1β by 71% (Fig. 1).
LANSO inhibits HpWE-induced TNF-α and IL-1β gene
expression and protein production
HpWE increased expression of mRNA for TNF-α by 48-
fold after two-hr incubation with HpWE. Similar to TNF-α,
HpWE induced expression of mRNA for IL-1β by 200-fold
after two-hr incubation with HpWE. HpWE induced protein
production of TNF-α and IL-1β after 3 h of incubation
with HpWE. Pretreatment with 100 μM LANSO for 3 h
decreased HpWE-induced expression of mRNA for TNF-α
by 27% and protein production of TNF-α by 48%. LPS also
inhibited expression of mRNA for IL-1β by 50% and protein
production of IL-1β by 93% (Fig. 2).
Inhibition of NF-κB and ERK decreases LPS-induced
production of TNF-α in THP-1 cells
To confirm the relevance of NF-κB and ERK to produc-
tion of TNF-α by THP-1 cells stimulated by LPS, we
examined the effects of PDTC, an inhibitor of NF-κB acti-
vation, and PD 98059, a MEK inhibitor. Pretreatment with
PDTC or PD98059 decreased the protein production of
TNF-α by THP-1 cells stimulated by LPS (Fig. 3) by 54%
and 34%, respectively. These findings indicate that acti-
vation of NF-κB and ERK is responsible for production of
TNF-α by THP-1 cells stimulated by LPS (Fig. 3).
LANSO inhibits LPS-induced phosphorylation and degrada-
tion of IκB-α and phosphorylation of ERK
Stimulation with LPS for one hr induced phosphorylation
and degradation of IκB-α and phosphorylation of ERK.
Pretreatment with LANSO for one hr inhibited LPS-induced
phosphorylation and degradation of IκB-α and phosphory-
lation of ERK (Fig. 4).
LANSO inhibits HpWE-induced phosphorylation and degra-
dation of IκB-α and phosphorylation of ERK
Similar to LPS, stimulation with HpWE for one hr
induced phosphorylation and degradation of IκB-α and
phosphorylation of ERK. Pretreatment with LANSO for one
hr inhibited HpWE-induced phosphorylation and degrada-
tion of IκB-α and phosphorylation of ERK (Fig. 5).
Discussion
In the present study, we demonstrated that LANSO
inhibits LPS and HpWE-induced transcription and produc-
tion of TNF-α and IL-1β. We also showed that LANSO
inhibited activation of NF-κB and ERK induced by LPS and
HpWE, which could account for why LANSO exerts anti-
inflammatory effects.
Production of proinflammatory cytokines such as TNF-α
and IL-1β by inflammatory cells is one of the pivotal
processes in gastrointestinal inflammation. In response to
interaction with pathogenic bacteria, inflammatory cellsLansoprazole Inhibits TNF-α and IL-1β Production
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produce proinflammatory cytokines, which activate further
inflammatory processes and promote inflammation. In the
present study, we showed that LANSO inhibits production
of TNF-α and IL-1β  by the monocytic cell line THP-1
stimulated by LPS or HpWE. Moreover, Nakamura et al.
reported that uptake of LANSO was observed in inflam-
matory cells including polymorphonuclear cells and macro-
phages in the colonic mucosa of rats with dextran sodium
sulfate-induced colitis [23]. These findings suggest that
LANSO may exert anti-inflammatory effects in gastro-
intestinal inflammation via suppression of production of
proinflammatory cytokines from inflammatory cells stimu-
lated by pathogenic bacteria.
Several reports have suggested mechanisms by which
LANSO and other proton pump inhibitors exert anti-
inflammatory effects [12–22]. In the present study, we
focused on the NF-κB and ERK signaling pathways, since
they are important transcription factors of critical impor-
tance for induction of production of proinflammatory cyto-
kines by monocytes stimulated by LPS [24–26] or HpWE
[27]. Our study demonstrated that the suppression of TNF-α
and IL-1β induced by LPS and HpWE was accompanied
by inhibition of phosphorylation and degradation of IκB-α
and phosphorylation of ERK. These findings suggest that
the inhibitory effect of LANSO on expression of TNF-α and
IL-1β by THP-1 cells stimulated by LPS and HpWE was
associated with inhibition of the NF-κB or ERK signaling
Fig. 1. Effects of LANSO on expression of TNF-α and IL-1β induced by LPS in human monocytes (THP-1). After pretreatment with
100 μM of LANSO for 3 h, THP-1 cells were stimulated with LPS (10 ng/ml) for up to 3 h. (A) Expression of mRNA for TNF-
α and (B) concentration of TNF-α protein in cell culture supernatant were determined by real-time quantitative RT-PCR and
ELISA, respectively. (C) Expression of mRNA for IL-1β and (D) concentration of IL-1β protein in cell culture supernatant were
determined by real-time quantitative RT-PCR and ELISA, respectively. Each column represents the mean ± SD of n =3
independent observations in three separate cell culture plates. **; p<0.01 compared with control. ##; p<0.01 compared with
LPS-stimulated vehicle-treated cells.T. Tanigawa et al.
J. Clin. Biochem. Nutr.
90
pathway via inhibition of phosphorylation and degradation
of IκB-α and phosphorylation of ERK. The precise
mechanism by which LANSO inhibits activation of NF-κB
and ERK remains unknown. LPS and HpWE act as ligands
of TLRs, and both NF-κB and ERK are downstream
signaling molecules of the TLRs-signaling pathway [9–11].
Taken together, these findings suggest the possibility that
LANSO suppresses phosphorylation and degradation of
IκB-α and phosphorylation of ERK via inhibition of the
TLR signaling pathway.
In summary, the present findings highlight the novel anti-
inflammatory effects of LANSO. LANSO suppressed
production of the proinflammatory cytokines TNF-α and IL-
1β by human monocytic cells stimulated by representative
pathogenic bacterial components in the gastrointestinal tract,
LPS and HpWE. LANSO is already clinically used for
peptic ulcer disease and reflux esophagitis, and it appears
possible to extend its clinical application to control of
inflammation of the gastrointestinal tract caused by patho-
genic bacteria in conditions such as inflammatory bowel
disease, chronic active gastritis, and NSAID-induced gastro-
intestinal injury.
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Fig. 2. Effects of LANSO on expression of TNF-α and IL-1β induced by HpWE in human monocytes (THP-1). After pretreatment
with 100 μM of LANSO for 3 h, THP-1 cells were stimulated with HpWE (5 μg/ml) for up to 3 h. (A) Expression of mRNA for
TNF-α and (B) concentration of TNF-α protein in cell culture supernatant were determined by real-time quantitative RT-PCR
and ELISA, respectively. (C) Expression of mRNA for IL-1β and (D) concentration of IL-1β protein in cell culture supernatant
were determined by real-time quantitative RT-PCR and ELISA, respectively. Each column represents the mean ± SD of n =3
independent observations in three separate cell culture plates. **; p<0.01 compared with control. #; p<0.05 and ##; p<0.01
compared with LPS-stimulated vehicle-treated cells.Lansoprazole Inhibits TNF-α and IL-1β Production
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